Standard
OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission : results from the biodam cohort. / Sepriano, A; Ramiro, S; Landewé, R; Heijde, D Van Der; Ohrndorf, S; Fitzgerald, O; Backhaus, M; Larché, M; Homik, J; Saraux, A; Hammer, H; Terslev, L; Østergaard, M; Burmester, G; Combe, B; Dougados, M; Hitchon, C; Boire, G; Dadashova, R; Paschke, J; Hutchings, E; Maksymowych, W.
In:
Annals of the Rheumatic Diseases, Vol. 76, No. Suppl 2, 2017, p. 131.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Sepriano, A, Ramiro, S, Landewé, R, Heijde, DVD, Ohrndorf, S, Fitzgerald, O, Backhaus, M, Larché, M, Homik, J, Saraux, A, Hammer, H, Terslev, L
, Østergaard, M, Burmester, G, Combe, B, Dougados, M, Hitchon, C, Boire, G, Dadashova, R, Paschke, J, Hutchings, E & Maksymowych, W 2017, '
OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort',
Annals of the Rheumatic Diseases, vol. 76, no. Suppl 2, pp. 131.
https://doi.org/10.1136/annrheumdis-2017-eular.1613APA
Sepriano, A., Ramiro, S., Landewé, R., Heijde, D. V. D., Ohrndorf, S., Fitzgerald, O., Backhaus, M., Larché, M., Homik, J., Saraux, A., Hammer, H., Terslev, L.
, Østergaard, M., Burmester, G., Combe, B., Dougados, M., Hitchon, C., Boire, G., Dadashova, R., ... Maksymowych, W. (2017).
OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort.
Annals of the Rheumatic Diseases,
76(Suppl 2), 131.
https://doi.org/10.1136/annrheumdis-2017-eular.1613Vancouver
Sepriano A, Ramiro S, Landewé R, Heijde DVD, Ohrndorf S, Fitzgerald O et al.
OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort.
Annals of the Rheumatic Diseases. 2017;76(Suppl 2):131.
https://doi.org/10.1136/annrheumdis-2017-eular.1613Author
Sepriano, A ; Ramiro, S ; Landewé, R ; Heijde, D Van Der ; Ohrndorf, S ; Fitzgerald, O ; Backhaus, M ; Larché, M ; Homik, J ; Saraux, A ; Hammer, H ; Terslev, L ; Østergaard, M ; Burmester, G ; Combe, B ; Dougados, M ; Hitchon, C ; Boire, G ; Dadashova, R ; Paschke, J ; Hutchings, E ; Maksymowych, W. / OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission : results from the biodam cohort. In: Annals of the Rheumatic Diseases. 2017 ; Vol. 76, No. Suppl 2. pp. 131.
Bibtex
@article{5e1f9711b2f24c1a91c603973aeeb35c,
title = "OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission: results from the biodam cohort",
author = "A Sepriano and S Ramiro and R Landew{\'e} and Heijde, {D Van Der} and S Ohrndorf and O Fitzgerald and M Backhaus and M Larch{\'e} and J Homik and A Saraux and H Hammer and L Terslev and M {\O}stergaard and G Burmester and B Combe and M Dougados and C Hitchon and G Boire and R Dadashova and J Paschke and E Hutchings and W Maksymowych",
year = "2017",
doi = "10.1136/annrheumdis-2017-eular.1613",
language = "English",
volume = "76",
pages = "131",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "Suppl 2",
}
RIS
TY - ABST
T1 - OP0192 Adding ultrasound to the treat-to-target strategy shows no benefit in achievement of remission
T2 - results from the biodam cohort
AU - Sepriano, A
AU - Ramiro, S
AU - Landewé, R
AU - Heijde, D Van Der
AU - Ohrndorf, S
AU - Fitzgerald, O
AU - Backhaus, M
AU - Larché, M
AU - Homik, J
AU - Saraux, A
AU - Hammer, H
AU - Terslev, L
AU - Østergaard, M
AU - Burmester, G
AU - Combe, B
AU - Dougados, M
AU - Hitchon, C
AU - Boire, G
AU - Dadashova, R
AU - Paschke, J
AU - Hutchings, E
AU - Maksymowych, W
PY - 2017
Y1 - 2017
U2 - 10.1136/annrheumdis-2017-eular.1613
DO - 10.1136/annrheumdis-2017-eular.1613
M3 - Conference abstract in journal
VL - 76
SP - 131
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
SN - 0003-4967
IS - Suppl 2
ER -
